logo-loader

XPhyto Therapeutics expedites development of 5-minute coronavirus saliva test in Germany

Published: 08:30 10 Aug 2020 EDT

Coronavirus graphic
3a’s enhanced RNA probe system has proven capable of detecting viral RNA in symptomatic, pre-symptomatic and asymptomatic patients alike

XPhyto Therapeutics Corp (CSE:XPHY) (OTCPINK:XPHYF) told investors Monday that development of its rapid saliva-based coronavirus (COVID-19) test is proceeding at an expedited basis at its diagnostic partner’s research lab in Germany. 

Xphyto and 3a Diagnostics GmbH are developing a point-of-care lateral flow test to detect viral RNA in patent saliva, as well as from nasal and throat swabs, in fewer than five minutes. 

3a’s enhanced RNA probe system has proven capable of detecting viral RNA in symptomatic, pre-symptomatic and asymptomatic patients alike, the company said.

READ: XPhyto Therapeutics says COVID-19 rapid screening test prototype achieves validation

The parties hope to win approval from European regulators in the first quarter of 2021, pending fast track certification from the German government, with commercial sales to follow soon after. 

In addition to COVID-19, the lateral flow is capable of detecting the broader family of coronaviruses. 

Prototype testing has confirmed successful activation of both the “COVID-19 specific probes” and the “universal coronavirus probes at viral RNA levels,” XPhyto noted in a statement.

The Vancouver-based company also announced that it is presenting at today’s Wall Street Reporter Next Super Stock Live virtual event at 12:30 pm ET.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Ramp Metals Launches Drilling Program in Pursuit of High-Grade Nickel in...

Ramp Metals CEO Jordan Black joined Steve Darling from Proactive to introduce the company to the public domain and share exciting developments in the mining industry. With a background as a geotechnical engineer and experience in venture capital, including a notable role in taking GoldSpot...

1 hour, 10 minutes ago